Acipimox

Modify Date: 2024-01-03 13:49:51

Acipimox Structure
Acipimox structure
Common Name Acipimox
CAS Number 51037-30-0 Molecular Weight 154.123
Density 1.4±0.1 g/cm3 Boiling Point 539.0±45.0 °C at 760 mmHg
Molecular Formula C6H6N2O3 Melting Point 177-180 °C
MSDS Chinese USA Flash Point 279.8±28.7 °C
Symbol GHS07
GHS07
Signal Word Warning

 Use of Acipimox


Acipimox is a niacin derivative used as a hypolipidemic agent.Target: Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. Long-term administration is associated with reduced mortality, but unwanted effects limit its clinical use. Adverse effects include flushing (associated with Prostaglandin D2), palpitations, and GI disturbances. Flushing can be reduced by taking aspirin 20-30 min before taking Acipimox. High doses can cause disorders of liver function, impair glucose tolerance and precipitate gout. From Wikipedia.

 Names

Name 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid
Synonym More Synonyms

 Acipimox Biological Activity

Description Acipimox is a niacin derivative used as a hypolipidemic agent.Target: Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. Long-term administration is associated with reduced mortality, but unwanted effects limit its clinical use. Adverse effects include flushing (associated with Prostaglandin D2), palpitations, and GI disturbances. Flushing can be reduced by taking aspirin 20-30 min before taking Acipimox. High doses can cause disorders of liver function, impair glucose tolerance and precipitate gout. From Wikipedia.
Related Catalog
References

[1]. http://en.wikipedia.org/wiki/Acipimox

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 539.0±45.0 °C at 760 mmHg
Melting Point 177-180 °C
Molecular Formula C6H6N2O3
Molecular Weight 154.123
Flash Point 279.8±28.7 °C
Exact Mass 154.037842
PSA 75.65000
LogP -1.38
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.608
Storage condition 2-8°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UQ2453000
CHEMICAL NAME :
2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide
CAS REGISTRY NUMBER :
51037-30-0
BEILSTEIN REFERENCE NO. :
0777471
LAST UPDATED :
199710
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C6-H6-N2-O3
MOLECULAR WEIGHT :
154.14
WISWESSER LINE NOTATION :
T6N DNJ AO B1 EVQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3500 mg/kg
TOXIC EFFECTS :
Biochemical - Metabolism (Intermediary) - lipids including transport
REFERENCE :
EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 15,157,1980

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H319
Precautionary Statements P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi: Irritant;
Risk Phrases R36
Safety Phrases S26
RIDADR NONH for all modes of transport
RTECS UQ2453000
HS Code 2942000000

 Synthetic Route

~%

Acipimox Structure

Acipimox

CAS#:51037-30-0

Literature: Carlo Erba S.p.A. Patent: US4002750 A1, 1977 ;

~%

Acipimox Structure

Acipimox

CAS#:51037-30-0

Literature: Carlo Erba S.p.A. Patent: US4002750 A1, 1977 ;

~%

Acipimox Structure

Acipimox

CAS#:51037-30-0

Literature: Montedison S.p.A. Patent: US4866178 A1, 1989 ;

~%

Acipimox Structure

Acipimox

CAS#:51037-30-0

Literature: Ambrogi; Cozzi; Sanjust; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 157 - 163

~%

Acipimox Structure

Acipimox

CAS#:51037-30-0

Literature: Ambrogi; Cozzi; Sanjust; et al. European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 157 - 163

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles30

More Articles
Kinetics and utilization of lipid sources during acute exercise and acipimox.

Am. J. Physiol. Endocrinol. Metab. 307(2) , E199-208, (2014)

Overweight is associated with abnormalities of lipid metabolism, many of which are reversed by exercise. We investigated the impact of experimental antilipolysis and acute exercise on lipid kinetics a...

The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans.

Am. J. Physiol. Endocrinol. Metab. 295(2) , E413-9, (2008)

Lipolysis may regulate liver free fatty acid (FFA) uptake and triglyceride accumulation; both are potential causes of insulin resistance and liver damage. We evaluated whether 1) systemic FFA release ...

ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.

Eur. J. Nucl. Med. Mol. Imaging 37(9) , 1745-50, (2010)

18F-Fluorodeoxyglucose (FDG) imaging, provided by current positron emission tomography (PET) systems dedicated to small animals,might provide a precise functional assessment of the left ventricle (LV)...

 Synonyms

5-methyl-2-pyrazinoic-4-oxide
2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide
2-Carboxy-5-methylpyrazine 4-oxide,5-Methylpyrazinecarboxylic acid 4-oxide
5-Carboxy-2-methylpyrazine 1-oxide
5-methyl-4-oxy-pyrazine-2-carboxylic acid
5-methylpyrazine-2-carboxylic acid 4-oxide
2-carboxy-5-methylpyrazine 4-oxide
Acipimox
K-9321
Olbetam
5-Methylpyrazinecarboxylic acid 4-oxide
5-Methyl-2-pyrazinecarboxylic acid 4-oxide
2-methyl-5-pyrazinecarboxylic acid 1-oxide
Olbemox
EINECS 256-928-3
T6N DNJ AO B1 EVQ
MFCD00865757
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Acipimox suppliers


Price: $94/10mM*1mLinDMSO

Reference only. check more Acipimox price